m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs

Lu Ding1, Huiran Wu1, Yi Wang2

  • 1Center for Translational Neurodegeneration and Regenerative Therapy, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai, China.

Insights

Researchers discovered that N6-methyladenosine (m6A) methylation patterns change in microglia during inflammation. The protein Igf2bp1 was identified as a key regulator of these m6A patterns and microglial activation.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia are the brain's resident phagocytic macrophages.
  • Microglial inflammatory responses are crucial in neurological disorders.
  • Intrinsic regulation of microglial inflammatory responses remains poorly understood.

Purpose of the Study:

  • To investigate the role of N6-methyladenosine (m6A) methylation in regulating microglial inflammatory responses.
  • To identify key molecular players involved in m6A-mediated microglial activation.

Main Methods:

  • Analysis of m6A methylation patterns in LPS-activated microglia.
  • High-throughput sequencing and molecular studies to identify m6A modifiers.
  • Functional perturbation studies to assess the role of Igf2bp1.

Main Results:

  • LPS-activated microglia show distinct m6A methylation patterns correlated with mRNA expression.
  • Igf2bp1 was identified as a significantly regulated m6A modifier in activated microglia.
  • Igf2bp1 enhances m6A methylation and stability of Gbp11 and Cp mRNAs, mediating microglial activation.

Conclusions:

  • m6A methylation plays a role in regulating microglial inflammatory responses.
  • Igf2bp1 is a key mediator of LPS-induced m6A modification and microglial activation.
  • Igf2bp1 represents a potential therapeutic target for modulating microglial inflammation.